In December 2025, the U.S. Food and Drug Administration gave the green light to a pill version of the blockbuster weight loss drug Wegovy, the first FDA-approved daily oral GLP-1 ...

The target action date for orforglipron is now April 10.

Wegovy pill is now approved by the US Food and Drug Administration (FDA). On Monday, the FDA approved a daily pill version of Novo Nordisk's weight loss drug Wegovy, which is now introducing a new ...

Add Yahoo as a preferred source to see more of our stories on Google. The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo Nordisk ...

(The Hill) – The Food and Drug Administration (FDA) has approved Novo Nordisk’s oral version of the Wegovy weight-loss pill, the first such supplement approved for use. Novo Nordisk said in a Tuesday ...

The US Food and Drug Administration (FDA) has approved a once-daily oral GLP‑1 medicine to help people reduce excess body weight and maintain weight loss over the long term. The Novo Nordisk treatment ...

The Food and Drug Administration has approved the first GLP-1 pill for weight loss, its manufacturer Novo Nordisk announced Monday, a milestone in the growth of the revolutionary drugs. The drug, a ...

About 20 years ago, the U.S. Food and Drug Administration approved the first GLP-1 medication for Type 2 diabetes. Today, the ...

As a youth activist in Colorado, I’ve spent years organizing around the issues that shape our generation’s lives — and across ...

U.S. regulators on Monday approved a pill version of the blockbuster weight-loss drug Wegovy, marking the first time a daily oral medication has been green-lit to treat obesity. The change is expected ...

The U.S. Food and Drug Administration has requested manufacturers of extremely popular diabetes and weight loss medications to remove a warning about possible increased risks of suicidal behavior and ...

U.S. regulators on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity. The FDA's approval handed drugmaker Novo ...